Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02402244 · ClinicalTrials.gov registry record
Project: Every Child for Younger Patients With Cancer
A clinical trial of Central Nervous System Neoplasm and Carcinoma in Situ, sponsored by Children's Oncology Group.
- Recruiting
- Registry status
- 75,000
- Enrollment target
- 20
- Study locations
NCT02402244 is a study of Central Nervous System Neoplasm and Carcinoma in Situ that is actively recruiting participants, run by Children's Oncology Group. The registered enrollment target is 75,000 participants, above the 126-participant average among 7 other Central Nervous System Neoplasm trials with a reported enrollment target (59424% higher). The trial reports 20 study locations across 5 states.
The verdict
NCT02402244, a study of Central Nervous System Neoplasm and Carcinoma in Situ, is actively recruiting participants, sponsored by Children's Oncology Group.
- RECRUITING
- Registry status
- 75,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.
Conditions Studied
Interventions
- OTHER Medical Chart Review
- OTHER Cytology Specimen Collection Procedure
Study Locations (20)
California
- Kaiser Permanente Downey Medical Center - Downey
- City of Hope Comprehensive Cancer Center - Duarte
- Loma Linda University Medical Center - Loma Linda
- Miller Children's and Women's Hospital Long Beach - Long Beach
- Children's Hospital Los Angeles - Los Angeles
- Cedars Sinai Medical Center - Los Angeles
- Mattel Children's Hospital UCLA - Los Angeles
- Valley Children's Hospital - Madera
- UCSF Benioff Children's Hospital Oakland - Oakland
- Kaiser Permanente-Oakland - Oakland
- Children's Hospital of Orange County - Orange
- Lucile Packard Children's Hospital Stanford University - Palo Alto
Arizona
- Kingman Regional Medical Center - Kingman
- Banner Children's at Desert - Mesa
- Phoenix Childrens Hospital - Phoenix
- Banner University Medical Center - Tucson - Tucson
Alabama
- Children's Hospital of Alabama - Birmingham
- USA Health Strada Patient Care Center - Mobile
Alaska
- Providence Alaska Medical Center - Anchorage
Arkansas
- Arkansas Children's Hospital - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75,000 participants |
| Start Date | 2015-11-03 |
| Est. Completion | 2030-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02402244
The ClinicalTrials.gov registry entry for NCT02402244 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 75,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 126-participant average among 7 other Central Nervous System Neoplasm trials with a reported enrollment target (59424% higher). The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Central Nervous System Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Medical Chart Review is the first listed.
NCT02402244 reports 20 study locations spanning 5 distinct geographic areas - top geographies include California, Arizona, Alabama.
Frequently Asked Questions
What is clinical trial NCT02402244 about?
NCT02402244 is a clinical study titled "Project: Every Child for Younger Patients With Cancer". This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.
What is the current status of trial NCT02402244?
This trial is currently recruiting. The enrollment target is 75,000 participants. The study started on 2015-11-03. Estimated completion is 2030-12-31.
What conditions does trial NCT02402244 study?
This clinical trial studies the following conditions: Central Nervous System Neoplasm, Carcinoma in Situ, Desmoid Fibromatosis, Adrenal Gland Pheochromocytoma, Ganglioneuroma.
What interventions are being tested in trial NCT02402244?
The interventions under investigation include: Medical Chart Review (OTHER), Cytology Specimen Collection Procedure (OTHER).
Who is sponsoring clinical trial NCT02402244?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02402244 being conducted?
This trial has 20 study locations across Alabama, Alaska, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Central Nervous System Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
RECRUITING
-
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
RECRUITING · Phase 2
-
Cerebrospinal Fluid Biomarkers for Brain Tumors
RECRUITING
-
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
ACTIVE NOT RECRUITING · Phase 2
-
Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia
ACTIVE NOT RECRUITING · Phase 2
-
Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.